Company A & B Pharma Srl with Fiscal Code 8958182
recorded a turnover of 2024 of
149.804,
with a net profit of
8.120
and having an average number of employees of
2.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
A & B Pharma Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
132.742
109.145
111.033
125.758
137.935
176.064
174.397
153.948
134.732
149.804
Total Income - EUR
132.755
109.145
111.125
125.758
137.935
176.064
174.397
153.948
135.267
150.141
Total Expenses - EUR
133.619
104.295
108.421
119.820
133.231
163.010
164.873
148.847
129.230
140.742
Gross Profit/Loss - EUR
-864
4.850
2.704
5.937
4.704
13.054
9.524
5.101
6.036
9.398
Net Profit/Loss - EUR
-2.018
4.058
1.569
4.680
3.529
11.952
8.264
3.905
4.991
8.120
Employees
2
3
3
2
3
3
4
3
2
2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 11.8%, from 134.732 euro in the year 2023, to 149.804 euro in 2024.
The Net Profit increased by 3.156 euro, from 4.991 euro in 2023, to 8.120 in the last year.
Check the financial reports for the company - A & B Pharma Srl
Financial Rating - A & B PHARMA SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - A & B Pharma Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - A & B Pharma Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - A & B Pharma Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
A & B Pharma Srl - CUI 8958182
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
23.793
23.403
23.030
22.608
22.170
21.750
21.267
21.333
21.269
21.150
Current Assets
17.579
18.167
18.412
22.893
22.798
29.147
31.380
27.725
21.960
26.721
Inventories
7.522
7.902
8.737
11.264
12.499
13.445
15.676
16.930
17.127
19.292
Receivables
8.825
8.635
8.489
8.333
8.172
8.017
7.374
7.863
923
0
Cash
1.232
1.630
1.186
3.296
2.127
7.685
8.329
2.932
3.910
7.430
Shareholders Funds
7.235
11.220
12.598
17.047
16.919
23.110
25.329
17.360
14.459
21.196
Social Capital
67
67
66
64
63
62
61
61
61
60
Debts
34.137
30.350
28.844
28.453
28.049
27.787
27.318
31.698
28.770
26.675
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
26.721 euro in 2024 which includes Inventories of
19.292 euro, Receivables of
0 euro and cash availability of
7.430 euro.
The company's Equity was valued at
21.196 euro, while total Liabilities amounted to
26.675 euro.
Equity increased by 6.818 euro, from 14.459 euro in 2023, to 21.196 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - A & B Pharma Srl